Publications found:
135
Sort by:
Global Glargine Insulin Pen Market Growth 2026-2032
US$ 3,660.00
The global Glargine Insulin Pen market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Glarg...
August 2026
100 pages
Global Oral Simeglutide Market Growth 2026-2032
US$ 3,660.00
The global Oral Simeglutide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Simeglutide was originally introdu...
August 2026
87 pages
Global Oral Semaglutide Market Growth 2026-2032
US$ 3,660.00
The global Oral Semaglutide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Oral Semaglutide is the first oral...
August 2026
95 pages
Sulfonylureas Market Size, Share and Growth Outlook 2026: By Drug Type (Glyburide, Glipizide, Glimepiride, Others), By Indication, By Dosage Form, By Route of Administration, By End-User, By Distribution Channel, Companies to 2034.
US$ 3,482.00
The global Sulfonylureas Market size is forecast to increase from $12.93 Billion in 2026 to $17.16 Billion in 2034 at a CAGR of 3.6% between 2026 and 2034. The Sulfonylureas market report provides det...
July 2026
190 pages
Incretin-Based Drugs Market - 2025-2033
US$ 3,400.00
Incretin-Based Drugs Market reached US$28.18 billion in 2025 and is expected to reach US$48.63 billion by 2035, growing with a CAGR of 5.60% during the forecast period 2026-2035. The Incretin-Based Dr...
July 2026
46 pages
South Korea Diabetes Drugs Market Report by Drug (Insulins, Oral Anti-diabetic Drugs, Non-Insulin Injectable Drugs, Combination Drugs), Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies), and Region 2026-2034
US$ 2,999.00
South Korea diabetes drugs market size reached USD 1.90 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 4.90 Billion by 2034, exhibiting a growth rate (CAGR) of 11.31% du...
July 2026
115 pages
South Korea Oral Anti-Diabetic Drug Market Report by Drugs (Biguanides, Alpha-Glucosidase Inhibitors, Dopamine D2 Receptor Agonist, SGLT-2 Inhibitors, DPP-4 Inhibitors, Sulfonylureas, Meglitinides), and Region 2026-2034
US$ 2,999.00
South Korea oral anti-diabetic drug market size reached USD 897.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,191.0 Million by 2034, exhibiting a growth rate (CAGR)...
July 2026
121 pages
Global Dual Incretin Agonists Market Size Study and Forecast by Drug (Tirzepatide, Survodutide, and Others), Disease Indication (Type 2 Diabetes, Obesity, MASH/NASH, and Others), Age Group (Pediatric and Adults), Type (Branded and Generics), Route of Administration (Subcutaneous, Oral, and Others), Distribution Channel, Regional Forecasts 2026-2036
US$ 3,750.00
The global dual incretin agonists market, valued at USD 36.51 billion in 2025, is anticipated to reach approximately USD 82.94 billion by 2036, growing at 7.75% CAGR during the forecast period. Dual i...
June 2026
285 pages
India GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Product (Semaglutide, Tirzepatide, Dulaglutide), By Application (Type 2 Diabetes Mellitus, Cardiovascular Risk), By Route Of Administration, By Distribution Channel, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The India GLP-1 receptor agonist market size was valued at USD 150.8 million in 2025 and is projected to grow from USD 240.5 million in 2026 to USD 1,004.9 million by 2033, at a CAGR of 22.7% from 202...
June 2026
150 pages
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs (Biguanides, Alpha-glucosidase inhibitors, Dopamine -D2 Receptor Agonist, Sodium-glucose Cotransport -2 (SGLT-2) inhibitor, Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors, Sulfonylureas, Meglitinides), By End Users (Hospitals, Homecare, Speciality Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Oral Anti-Diabetic Drugs Market is projected to expand significantly from USD 18.67 Billion in 2025 to USD 28.07 Billion by 2031, demonstrating a robust 7.03% CAGR. These orally administere...
May 2026
185 pages
Diabetic Gastroparesis Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Grade 2(Compensated Gastroparesis), Grade 3(Gastric Failure), By Drug Class (Gastroprokinetic Agents, Antiemetic Agents, Antihistamines, Others), By Route of Administration (Oral, Parenteral, Nasal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for diabetic gastroparesis treatments is projected to expand from USD 3.03 Billion in 2025 to USD 3.74 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 3.57%. This...
May 2026
180 pages
